Mitchell Kapoor
Stock Analyst at H.C. Wainwright
(4.70)
# 737
Out of 4,468 analysts
702
Total ratings
47.9%
Success rate
14.8%
Average return
Main Sectors:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Reiterated: Sell | $5 | $19.28 | -74.07% | 32 | Jul 1, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $7 | $2.10 | +233.33% | 4 | Jun 30, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $70 | $35.34 | +98.08% | 34 | Jun 30, 2026 | |
| EVMN Evommune | Downgraded: Hold | n/a | $12.96 | - | 6 | Jun 30, 2026 | |
| INCY Incyte | Reiterated: Buy | $140 | $116.86 | +19.80% | 13 | Jun 29, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Reiterated: Buy | kr 550.00 | $479.00 | +14.82% | 4 | Jun 29, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $125 → $130 | $81.80 | +58.92% | 26 | Jun 25, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $120 | $85.21 | +40.83% | 17 | Jun 23, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | $50 | $58.99 | -15.24% | 9 | Jun 22, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $95 | $79.45 | +19.57% | 57 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $17.56 | +42.37% | 15 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $29.98 | +50.10% | 1 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $14.05 | +220.28% | 24 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.89 | +181.21% | 20 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $65 | $29.91 | +117.32% | 60 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.09 | - | 7 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.42 | - | 31 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.65 | +36.99% | 9 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $10.59 | +136.07% | 23 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $13.92 | +43.68% | 3 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $14.00 | +7.14% | 22 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.43 | +105.76% | 28 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 | $26.50 | -5.66% | 22 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $35 | $18.84 | +85.77% | 7 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $30.62 | +46.96% | 35 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $3.82 | +187.96% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $25 | $17.41 | +43.60% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $60.08 | +33.16% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $4.69 | +113.22% | 16 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.73 | - | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.50 | +60.00% | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.26 | +455.56% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $5.17 | -61.32% | 9 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $7.34 | +240.60% | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.82 | n/a | 26 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0061 | n/a | 16 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.7713 | n/a | 24 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.40 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $4.60 | n/a | 6 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.97 | n/a | 8 | Aug 11, 2023 |
Sarepta Therapeutics
Jul 1, 2026
Reiterated: Sell
Price Target: $5
Current: $19.28
Upside: -74.07%
Palisade Bio
Jun 30, 2026
Reiterated: Buy
Price Target: $7
Current: $2.10
Upside: +233.33%
Neurogene
Jun 30, 2026
Reiterated: Buy
Price Target: $70
Current: $35.34
Upside: +98.08%
Evommune
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $12.96
Upside: -
Incyte
Jun 29, 2026
Reiterated: Buy
Price Target: $140
Current: $116.86
Upside: +19.80%
Swedish Orphan Biovitrum AB (publ)
Jun 29, 2026
Reiterated: Buy
Price Target: kr 550.00
Current: $479.00
Upside: +14.82%
Ionis Pharmaceuticals
Jun 25, 2026
Reiterated: Buy
Price Target: $125 → $130
Current: $81.80
Upside: +58.92%
Oruka Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $120
Current: $85.21
Upside: +40.83%
BioMarin Pharmaceutical
Jun 22, 2026
Reiterated: Hold
Price Target: $50
Current: $58.99
Upside: -15.24%
Halozyme Therapeutics
Jun 16, 2026
Reiterated: Buy
Price Target: $95
Current: $79.45
Upside: +19.57%
Jun 15, 2026
Reiterated: Buy
Price Target: $25
Current: $17.56
Upside: +42.37%
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $29.98
Upside: +50.10%
Jun 9, 2026
Reiterated: Buy
Price Target: $45
Current: $14.05
Upside: +220.28%
Jun 4, 2026
Reiterated: Buy
Price Target: $25
Current: $8.89
Upside: +181.21%
Jun 3, 2026
Reiterated: Buy
Price Target: $50 → $65
Current: $29.91
Upside: +117.32%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $17.09
Upside: -
Jun 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $15.42
Upside: -
May 26, 2026
Reiterated: Buy
Price Target: $5
Current: $3.65
Upside: +36.99%
May 26, 2026
Maintained: Buy
Price Target: $25
Current: $10.59
Upside: +136.07%
May 26, 2026
Reiterated: Buy
Price Target: $20
Current: $13.92
Upside: +43.68%
May 26, 2026
Maintained: Buy
Price Target: $15
Current: $14.00
Upside: +7.14%
May 26, 2026
Reiterated: Buy
Price Target: $5
Current: $2.43
Upside: +105.76%
May 15, 2026
Downgraded: Hold
Price Target: $25
Current: $26.50
Upside: -5.66%
May 14, 2026
Reiterated: Buy
Price Target: $40 → $35
Current: $18.84
Upside: +85.77%
May 14, 2026
Reiterated: Buy
Price Target: $45
Current: $30.62
Upside: +46.96%
May 11, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $3.82
Upside: +187.96%
May 8, 2026
Rated: Buy
Price Target: $16 → $25
Current: $17.41
Upside: +43.60%
May 5, 2026
Reiterated: Buy
Price Target: $80
Current: $60.08
Upside: +33.16%
Jan 13, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $4.69
Upside: +113.22%
Jan 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.73
Upside: -
Oct 24, 2025
Reiterated: Buy
Price Target: $4
Current: $2.50
Upside: +60.00%
Oct 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.26
Upside: +455.56%
Aug 19, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $5.17
Upside: -61.32%
Aug 11, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $7.34
Upside: +240.60%
Apr 30, 2025
Rated: Hold
Price Target: n/a
Current: $15.82
Upside: n/a
Apr 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.0061
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $9
Current: $0.7713
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $15
Current: $6.40
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $15
Current: $4.60
Upside: n/a
Aug 11, 2023
Reiterated: Hold
Price Target: n/a
Current: $1.97
Upside: n/a